vs
ALLIANCE ENTERTAINMENT HOLDING CORP（AENT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
ALLIANCE ENTERTAINMENT HOLDING CORP的季度营收约是REPLIGEN CORP的1.9倍（$368.7M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 2.5%，领先4.2%），REPLIGEN CORP同比增速更快（13.6% vs -6.3%），REPLIGEN CORP自由现金流更多（$17.6M vs $-16.9M），过去两年ALLIANCE ENTERTAINMENT HOLDING CORP的营收复合增速更高（32.1% vs 14.4%）
该企业是一家总部位于加拿大多伦多的传媒公司，核心业务为加拿大市场提供专业特色媒体服务，除多伦多总部外，还在哈利法克斯、洛杉矶、伦敦、都柏林、马德里、巴塞罗那、香农以及悉尼多地设有办事机构。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AENT vs RGEN — 直观对比
营收规模更大
AENT
是对方的1.9倍
$197.9M
营收增速更快
RGEN
高出20.0%
-6.3%
净利率更高
RGEN
高出4.2%
2.5%
自由现金流更多
RGEN
多$34.5M
$-16.9M
两年增速更快
AENT
近两年复合增速
14.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $368.7M | $197.9M |
| 净利润 | $9.4M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 4.7% | 9.0% |
| 净利率 | 2.5% | 6.7% |
| 营收同比 | -6.3% | 13.6% |
| 净利润同比 | 32.8% | 143.9% |
| 每股收益（稀释后） | $0.18 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AENTRGEN
| Q4 25 | $368.7M | $197.9M | ||
| Q3 25 | $254.0M | $188.8M | ||
| Q2 25 | $227.8M | $182.4M | ||
| Q1 25 | $213.0M | $169.2M | ||
| Q4 24 | $393.7M | $174.1M | ||
| Q3 24 | $229.0M | $154.9M | ||
| Q2 24 | $236.9M | $154.1M | ||
| Q1 24 | $211.2M | $151.3M |
净利润AENTRGEN
| Q4 25 | $9.4M | $13.3M | ||
| Q3 25 | $4.9M | $14.9M | ||
| Q2 25 | $5.8M | $14.9M | ||
| Q1 25 | $1.9M | $5.8M | ||
| Q4 24 | $7.1M | $-30.3M | ||
| Q3 24 | $397.0K | $-654.0K | ||
| Q2 24 | $2.5M | $3.3M | ||
| Q1 24 | $-3.4M | $2.1M |
毛利率AENTRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率AENTRGEN
| Q4 25 | 4.7% | 9.0% | ||
| Q3 25 | 4.2% | 8.9% | ||
| Q2 25 | 4.3% | 7.6% | ||
| Q1 25 | 1.7% | 3.9% | ||
| Q4 24 | 3.8% | -17.7% | ||
| Q3 24 | 0.9% | -5.1% | ||
| Q2 24 | 0.2% | 1.0% | ||
| Q1 24 | -0.3% | 1.3% |
净利率AENTRGEN
| Q4 25 | 2.5% | 6.7% | ||
| Q3 25 | 1.9% | 7.9% | ||
| Q2 25 | 2.5% | 8.2% | ||
| Q1 25 | 0.9% | 3.4% | ||
| Q4 24 | 1.8% | -17.4% | ||
| Q3 24 | 0.2% | -0.4% | ||
| Q2 24 | 1.1% | 2.2% | ||
| Q1 24 | -1.6% | 1.4% |
每股收益（稀释后）AENTRGEN
| Q4 25 | $0.18 | $0.24 | ||
| Q3 25 | $0.10 | $0.26 | ||
| Q2 25 | $0.11 | $0.26 | ||
| Q1 25 | $0.04 | $0.10 | ||
| Q4 24 | $0.14 | $-0.55 | ||
| Q3 24 | $0.01 | $-0.01 | ||
| Q2 24 | $0.05 | $0.06 | ||
| Q1 24 | $-0.07 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $117.6M | $2.1B |
| 总资产 | $434.1M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AENTRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $4.3M | $784.0M | ||
| Q2 24 | $1.1M | $809.1M | ||
| Q1 24 | $1.6M | $780.6M |
总债务AENTRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AENTRGEN
| Q4 25 | $117.6M | $2.1B | ||
| Q3 25 | $108.1M | $2.1B | ||
| Q2 25 | $103.2M | $2.1B | ||
| Q1 25 | $97.4M | $2.0B | ||
| Q4 24 | $95.6M | $2.0B | ||
| Q3 24 | $88.0M | $2.0B | ||
| Q2 24 | $87.6M | $2.0B | ||
| Q1 24 | $85.1M | $2.0B |
总资产AENTRGEN
| Q4 25 | $434.1M | $2.9B | ||
| Q3 25 | $383.0M | $2.9B | ||
| Q2 25 | $361.2M | $2.9B | ||
| Q1 25 | $349.4M | $2.9B | ||
| Q4 24 | $401.7M | $2.8B | ||
| Q3 24 | $395.7M | $2.8B | ||
| Q2 24 | $340.8M | $2.9B | ||
| Q1 24 | $324.0M | $2.8B |
负债/权益比AENTRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.5M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-16.9M | $17.6M |
| 自由现金流率自由现金流/营收 | -4.6% | 8.9% |
| 资本支出强度资本支出/营收 | 0.1% | 4.1% |
| 现金转化率经营现金流/净利润 | -1.76× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-1.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流AENTRGEN
| Q4 25 | $-16.5M | $25.7M | ||
| Q3 25 | $2.7M | $48.1M | ||
| Q2 25 | $10.7M | $28.6M | ||
| Q1 25 | $2.5M | $15.0M | ||
| Q4 24 | $25.3M | $39.2M | ||
| Q3 24 | $-11.6M | $49.3M | ||
| Q2 24 | $9.7M | $42.2M | ||
| Q1 24 | $20.0M | $44.7M |
自由现金流AENTRGEN
| Q4 25 | $-16.9M | $17.6M | ||
| Q3 25 | $2.4M | $43.4M | ||
| Q2 25 | $10.7M | $21.5M | ||
| Q1 25 | $2.4M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | $-11.6M | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | $20.0M | $36.4M |
自由现金流率AENTRGEN
| Q4 25 | -4.6% | 8.9% | ||
| Q3 25 | 0.9% | 23.0% | ||
| Q2 25 | 4.7% | 11.8% | ||
| Q1 25 | 1.1% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | -5.1% | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | 9.4% | 24.0% |
资本支出强度AENTRGEN
| Q4 25 | 0.1% | 4.1% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.0% | 2.1% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | 0.0% | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | 0.0% | 5.5% |
现金转化率AENTRGEN
| Q4 25 | -1.76× | 1.93× | ||
| Q3 25 | 0.56× | 3.23× | ||
| Q2 25 | 1.86× | 1.92× | ||
| Q1 25 | 1.33× | 2.57× | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | -29.31× | — | ||
| Q2 24 | 3.85× | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
